Site Search

Displaying results 131 - 140 of 503

BIOMAP

Biomarkers in atopic dermatitis and psoriasis

COMPACT

Collaboration on the optimisation of macromolecular pharmaceutical access to cellular targets

Closed IMI1 Biologicals Drug delivery

A blue ECG line on a black background. The care pathway for cardiovascular diseases is complex.

24/06/2025

Collaborating for cardiovascular care

GRACE is a new IHI project that aims to deliver a smoother care pathway for cardiovascular diseases, from diagnosis to treatment and long-term management.

A young couple consult the apps to find out information about their medication. Image by Chay_Tee via Shutterstock.

11/06/2024

Trusted, easy-to-read electronic medical information in your pocket

Both the PharmaLedger and Gravitate-Health projects are developing solutions that will make it easier and safer for patients to access digital information about their medical...

Doctor using stethoscope to examine child's lungs for severe asthma symptoms and treatment.

01/06/2023

IMI project creates common standards to boost severe asthma research

The standards were developed by a multi-stakeholder group including people living with asthma as well as doctors, pharmaceutical companies, and health policymakers.

Abstract illustration of health data analysis representing the EHDEN project’s knee surgery research

26/11/2019

20 years of research replicated in five-day hackathon

IMI’s EHDEN project dramatically demonstrated the power of using clinical data in research by replicating, during a five-day ‘study-a-thon’, the results of a systematic review...

A scan of a mouse with the CD163-targeting immunotracers lit up in red and green. The large white parts are the kidneys. Image credit: Immune-Image project.

06/03/2025

New immunotracers indicate whether immunotherapy will work

New tools developed by the Immune-Image project can indicate the presence of cells that inhibit immunotherapy.

PRISM

Psychiatric Ratings using Intermediate Stratified Markers: providing quantitative biological measures to facilitate the discovery and development of new treatments for social and cognitive deficits in AD, SZ, and MD